Advertisement
Research Article| Volume 125, ISSUE 7, P1077-1082, April 01, 2020

Utility of the Modified Frailty Index to Predict Cardiac Resynchronization Therapy Outcomes and Response

Published:January 09, 2020DOI:https://doi.org/10.1016/j.amjcard.2019.12.049
      The aim of the present study was to investigate the utility of the modified frailty index (mFI) to predict outcomes in patients who underwent cardiac resynchronization therapy (CRT) device implantation. A retrospective cohort study of patients undergoing CRT implantation or upgrade over a 5-year period was performed. The relation between the preprocedural 11-component mFI and clinical outcomes including 1-year mortality, periprocedural and 30-day adverse events, 30-day readmission, length of hospitalization after procedure, and response to CRT defined by changes in left ventricular ejection fraction and end-diastolic volume were studied. Of 283 patients studied, 134 (47.3%) were classified as frail (mFI ≥3). Frailty was associated with an increased risk of 1-year mortality (hazard ratio 5.87, p = 0.033 in multivariate analysis), and increased frequency of adverse events (p = 0.013), 30-day readmission (p = 0.0077), and postprocedural length of stay ≥3 days (p = 0.0005). Frail patients had significantly less echocardiographic response to CRT compared with nonfrail patients with change in left ventricular ejection fraction 6% versus 12% (p = 0.004) and change in left ventricular end-diastolic volume −19.9 versus −43.3 ml (p = 0.006). In conclusion, frailty as assessed by the mFI is associated with an increase in 1-year mortality, adverse events, 30-day readmission, length of stay, and poorer response to CRT after implantation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dominguez-Rodriguez A
        • Abreu-Gonzalez P
        • Jimenez-Sosa A
        • Gonzalez J
        • Caballero-Estevez N
        • Martín-Casañas FV
        • Lara-Padron A
        • Aranda Jr, JM
        The impact of frailty in older patients with non-ischaemic cardiomyopathy after implantation of cardiac resynchronization therapy defibrillator.
        Europace. 2015; 17: 598-602
        • Kubala M
        • Guédon-Moreau L
        • Anselme F
        • Klug D
        • Bertaina G
        • Traullé S
        • Buiciuc O
        • Savouré A
        • Diouf M
        • Hermida JS
        Utility of frailty assessment for elderly patients undergoing cardiac resynchronization therapy.
        JACC Clin Electrophysiol. 2017; 3: 1523-1533
        • Mlynarska A
        • Mlynarski R
        • Golba KS
        Frailty as a predictor of negative outcomes after cardiac resynchronization therapy.
        Pacing Clin Electrophysiol. 2018; 41: 572-577
        • Mlynarska A
        • Mlynarski R
        • Biernat J
        • Sosnowski M
        • Golba KS
        Frailty syndrome in heart failure patients who are receiving cardiac resynchronization.
        Pacing Clin Electrophysiol. 2016; 39: 370-374
        • Mlynarska A
        • Mlynarski R
        • Marcisz C
        • Golba KS
        Modified frailty as a novel factor in predicting the response to cardiac resynchronization in the elderly population.
        Clin Interv Aging. 2019; 14: 437-443
        • Rowe R
        • Iqbal J
        • Murali-Krishnan R
        • Sultan A
        • Orme R
        • Briffa N
        • Denvir M
        • Gunn J
        Role of frailty assessment in patients undergoing cardiac interventions.
        Open Heart. 2014; 1e000033
        • Tsiouris A
        • Hammoud ZT
        • Velanovich V
        • Hodari A
        • Borgi J
        • Rubinfeld I
        A modified frailty index to assess morbidity and mortality after lobectomy.
        J Surg Res. 2013; 183: 40-46
        • Ali R
        • Schwalb JM
        • Nerenz DR
        • Antoine HJ
        • Rubinfeld I
        Use of the modified frailty index to predict 30-day morbidity and mortality from spine surgery.
        J Neurosurg Spine. 2016; 25: 537-541
        • Ali TZ
        • Lehman EB
        • Aziz F
        Modified frailty index can be used to predict adverse outcomes and mortality after lower extremity bypass surgery.
        Ann Vasc Surg. 2017; 46: 168-177
        • Vermillion SA
        • Hsu FC
        • Dorrell RD
        • Shen P
        • Clark CJ
        Modified frailty index predicts postoperative outcomes in older gastrointestinal cancer patients.
        J Surg Oncol. 2017; 115: 997-1003
        • Wahl TS
        • Graham LA
        • Hawn MT
        • Richman J
        • Hollis RH
        • Jones CE
        • Copeland LA
        • Burns EA
        • Itani KM
        • Morris MS
        Association of the modified frailty index with 30-day surgical readmission.
        JAMA Surg. 2017; 152: 749-757
        • Fumagalli S
        • Potpara TS
        • Bjerregaard Larsen T
        • Haugaa KH
        • Dobreanu D
        • Proclemer A
        • Dagres N
        Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey.
        Europace. 2017; 19: 1896-1902
        • Gajdos C
        • Kile D
        • Hawn MT
        • Finlayson E
        • Henderson WG
        • Robinson TN
        The significance of preoperative impaired sensorium on surgical outcomes in nonemergent general surgical operations.
        JAMA Surg. 2015; 150: 30-36
        • Jamerson D
        • McNitt S
        • Polonsky S
        • Zareba W
        • Moss A
        • Tompkins C
        Early procedure-related adverse events by gender in MADIT-CRT.
        J Cardiovasc Electrophysiol. 2014; 25: 985-989
        • Denfeld QE
        • Winters-Stone K
        • Mudd JO
        • Gelow JM
        • Kurdi S
        • Lee CS
        The prevalence of frailty in heart failure: a systematic review and meta-analysis.
        Int J Cardiol. 2017; 236: 283-289
        • Fried LP
        • Tangen CM
        • Walston J
        • Newman AB
        • Hirsch C
        • Gottdiener J
        • Seeman T
        • Tracy R
        • Kop WJ
        • Burke G
        • McBurnie MA
        • Cardiovascular Health Study Collaborative Research Group
        Frailty in older adults: evidence for a phenotype.
        J Gerontol A Biol Sci Med Sci. 2001; 56: M146-M156
        • Baitar A
        • Van Fraeyenhove F
        • Vandebroek A
        • De Droogh E
        • Galdermans D
        • Mebis J
        • Schrijvers D
        Evaluation of the Groningen frailty indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer.
        J Geriatr Oncol. 2013; 4: 32-38
        • Yokoshiki H
        • Mitsuyama H
        • Watanabe M
        • Mitsuhashi T
        • Shimizu A
        Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy.
        J Arrhythm. 2017; 33: 410-416
        • Leong DP
        • Teo KK
        • Rangarajan S
        • Lopez-Jaramillo P
        • Avezum Jr, A
        • Orlandini A
        • Seron P
        • Ahmed SH
        • Rosengren A
        • Kelishadi R
        • Rahman O
        • Swaminathan S
        • Iqbal R
        • Gupta R
        • Lear SA
        • Oguz A
        • Yusoff K
        • Zatonska K
        • Chifamba J
        • Igumbor E
        • Mohan V
        • Anjana RM
        • Gu H
        • Li W
        • Yusuf S
        • Prospective Urban Rural Epidemiology (PURE) Study investigators
        Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study.
        Lancet. 2015; 386: 266-273